Clinical Trials Issues Related to COVID-19

overview icon Overview

The COVID-19 pandemic has turned our world upside down. And, within the clinical trials community, nearly every aspect of research is experiencing unprecedented disruptions.

To help, several CTTI efforts are underway -- including conducting surveys, holding webinars, and developing resources -- with the goal of helping the clinical trials ecosystem adapt and move forward during this pandemic. Recordings are now available of two CTTI webinars on designing high-quality, streamlined COVID-19 trials and identifying best practices for conducting clinical trials with the new FDA guidance during the COVID-19 pandemic. CTTI has also created a best practices document and a daily searchable spreadsheet of the COVID-19-related studies posted on  

For more resources that can help, please see the "Deliverables" section below and follow CTTI on LinkedIn and Twitter.